While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.
Increasing the use of vaccines could help tackle the growing threat of antimicrobial resistance (AMR) by reducing the need for antibiotics by 22% globally—or 2.5 billion defined daily doses—every year ...
Antibiotics could become useless in as little as 12 years, a leading medical expert has warned. Common diseases now treatable by the drugs would then become killers, according to Professor Hugh ...
Eating GM food can change the genetic make-up of your digestive system and could put you at risk of infections that are resistant to antibiotics, experts said yesterday. A British study has ...
Also, the manufacturing and marketing clearance will have to be obtained from the Central government instead of State drug administration, and patients will be able to buy antibiotics only on ...